Therapeutic Effect of Plasmapheresis and Intravenous Immunoglobulin in Recipients of Kidney Transplant With High Panel-reactive Antibody Levels: A Single-center Experience

Sendogan, Damla; Saritas, Hazen; Kumru, GİZEM; Erdogmus, Siyar; TÜZÜNER, ACAR; KEVEN, KENAN; ŞENGÜL, ŞULE

doi:10.1016/j.transproceed.2019.04.073

Therapeutic Effect of Plasmapheresis and Intravenous Immunoglobulin in Recipients of Kidney Transplant With High Panel-reactive Antibody Levels: A Single-center Experience

Atıf İçin Kopyala

Sendogan D. O., Saritas H., Kumru G., Erdogmus S., TÜZÜNER A., KEVEN K., ...Daha Fazla

TRANSPLANTATION PROCEEDINGS, cilt.51, sa.7, ss.2254-2256, 2019 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 51 Sayı: 7
Basım Tarihi: 2019
Doi Numarası: 10.1016/j.transproceed.2019.04.073
Dergi Adı: TRANSPLANTATION PROCEEDINGS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.2254-2256
Ankara Üniversitesi Adresli: Evet

Özet

Objective. High panel-reactive antibody (PRA) levels limit patients' access to kidney transplantation from potential living donor candidates and decrease renal graft survival by causing acute antibody-mediated rejection (AAMR). In this article, we report our experiences about the efficiency of plasmapheresis (PP) and intravenous immunoglobulin (IVIG) in reduction of serum PRA levels in candidates for renal transplantation and in patients with AAMR.